by gbsaadmin | Jun 14, 2011 | Featured, Health, News
Pretoria – After encouraging results on a vaginal gel containing the antiretroviral drug tenofovir, which reduces HIV infection and risk of contracting genital herpes, a follow-up study to test the safety of the gel has been launched. The Phase III trial, to be known...
